| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | EVP & Chief Financial Officer
5 companies
Art A Garcia is Director at ELAN, with reported holdings spanning 5 companies. Art A Garcia's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $10.3M at current prices.
Our model assigns Art A Garcia a below-average insider score of 45/100, based on 3 past trades. Over a 12-month horizon, 33.3% of those trades were profitable, with an average 12-month return of +0.7%.
Art A Garcia's largest disclosed position is in R as EVP & Chief Financial Officer, worth about $4.3M. The R filings lean toward selling, a net 7,617 shares.
Art A Garcia has 96 Form 4 filings on record from February 2016 to September 2026, across 5 companies: Director at American Electric Power (AEP), 2019–2026; Director at Elanco Animal Health (ELAN), 2019–2026; Director at Raymond James Financial (RJF), 2023–2026, and 2 more.
The 116 reported transactions were 49 stock awards, 38 option or other derivative awards, 8 tax withholdings and 7 option exercises, plus smaller numbers of other types.
Counted by filing, the open-market trades come to 4 purchases worth about $272K and 3 sales worth about $549K.
The largest open-market purchase was 879 shares of RJF at an average $112.30 on February 9, 2024, about $99K. Twelve months later RJF was up 46%.
The largest open-market sale was 3,412 shares of R at an average $76.82 on July 30, 2018, about $262K.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 9, 2024 | RJF Raymond James Financial Inc | Director | Buy | 879 | $112.30 | $98,715.48 | New | +8.9% | +45.7% | |
| Sep 13, 2021 | ABM Abm Industries Inc /de/ | Director | Buy | 1,600 | $46.26 | $74,012.16 | +10.3% | -0.7% | -8.2% | |
| May 11, 2021 | ELAN Elanco Animal Health Inc | Director | Buy | 1,525 | $32.88 | $50,142.00 | +10.2% | -8.2% | -35.6% | |
| Aug 6, 2020 | ELAN Elanco Animal Health Inc | Director | Buy | 2,000 | $24.76 | $49,520.00 | +28.3% | - | - | |
| Jul 30, 2018 | R Ryder System Inc | EVP & Chief Financial Officer | Sale+OE | 3,412 | $76.82 | $262,110.18 | -21.3% | - | - | |
| Feb 15, 2017 | R Ryder System Inc | EVP & Chief Financial Officer | Sell | 2,205 | $78.83 | $173,827.65 | -18.1% | - | - | |
| Feb 19, 2016 | R Ryder System Inc | EVP & Chief Financial Officer | Sell | 2,000 | $56.38 | $112,753.60 | -9.5% | - | - |